Company intelligence / Profile preview

Reach Pharmaceuticals

Raleigh, North Carolina, United Statesreachpharma.com ↗

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Reach Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of high-quality, affordable medicines. The company leverages advanced drug delivery systems and repurposing strategies to address unmet medical needs in areas such as oncology, rare diseases, and neurological disorders. Reach Pharmaceuticals aims to improve patient outcomes by enhancing the efficacy and safety profiles of existing therapeutic agents. Their business model emphasizes strategic partnerships and a lean operational structure to accelerate the path from development to market.

Therapeutic areas: OncologyNeurologyRare Diseases
Modalities: Small moleculeDrug delivery system
Industry: Biotech

Drug pipeline

10 assets

TBRIFISO001

9 more assets in the full pipeline.

Beyond the preview

Go deeper on Reach Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reach Pharmaceuticals.